PRIMARY THROMBOCYTHEMIA - CLONAL ORIGIN OF PLATELETS, ERYTHROCYTES, AND GRANULOCYTES IN A GDB GDMEDITERRANEAN SUBJECT
- 1 January 1982
- journal article
- research article
- Vol. 59 (1) , 76-79
Abstract
A patient with primary thrombocythemia, who was heterozygous for glucose-6-phosphate dehydrogenase deficiency (GdB/GdMed), was investigated to test for the clonal origin of this myeloproliferative disorder. To assess somatic cell mosaicism in various tissues, the different rate of utilization of 2-deoxyglucose-6-phosphate, an analog of glucose-6-phosphate, by normal glucose-6-phosphate dehydrogenase and by the Mediterranean variant was used. Essential thrombocythemia is apparently a clonal disease involving the erythrocytic, granulocytic and megakaryocytic series without affecting monocytes, T lymphocytes and non-T lymphocytes.This publication has 7 references indexed in Scilit:
- UNICELLULAR OR MULTICELLULAR ORIGIN OF HUMAN GRANULOCYTE-MACROPHAGE COLONIES INVITRO1979
- Chronic Myelocytic LeukemiaJournal of Clinical Investigation, 1978
- Biochemical mechanisms of glucose-6-phosphate dehydrogenase deficiency.Proceedings of the National Academy of Sciences, 1978
- AGNOGENIC MYELOID METAPLASIA - CLONAL PROLIFERATION OF HEMATOPOIETIC STEM-CELLS WITH SECONDARY MYELOFIBROSIS1978
- Chronic myelocytic leukemia: Clonal origin in a stem cell common to the granulocyte, erythrocyte, platelet and monocyte/macrophageThe American Journal of Medicine, 1977
- Polycythemia Vera: Stem-Cell and Probable Clonal Origin of the DiseaseNew England Journal of Medicine, 1976
- REMOVAL OF LEUKOCYTES AND PLATELETS FROM WHOLE-BLOOD1976